INTEREST IN SINUS NODE DYSFUNCTION has grown in recent years with identification of electrocardiographic criteria for sick sinus syndrome.1-6 Reports have appeared describing the clinical features'-" or electrophysiologic studies36-46 or postmortem findings in this group of patients.15, 16, 21, 30, 47-51 Although the electrocardiographic criteria for diagnosis of sick sinus syndrome have gained wide acceptance, the evaluation of such patients in the clinic can often be difficult, particularly when a patient does not have full blown features of the syndrome. Symptomatology is not only importantly related to the severity of the bradyarrhythmia(s) but also is related to the nature and severity of the tachyarrhythmia(s) and to the coexistence of cerebrovascular and cardiac disease.
A variety of interventions have been offered as a means of identifying sinus node dysfunction,37 40-42, 52 but at present it is not clear that they do anything more than identify those patients with overt features of the sick sinus syndrome. Interpretations of data derived from the use of these interventions are facilitated by consideration of data obtained from in vitro electrophysiologic studies. 53 In the rabbit heart, electrical activity in the sinus node is generated by automatic pacemaker cells and the impulse so formed propagates toward the crista terminalis to activate the atrium. 53 Hence, in the rabbit, and presumably in man, absence of atrial depolarization can reflect disturbance of sinus node automaticity and/or sinoatrial conduction. Thus, it may be useful to employ electrophysiologic tests which assess both sinus node automaticity and sinoatrial conduc-value equal to 1.3 X the mean value of the control cycle length + 101 msec (slope of regression line + Y intercept + I SDd in 13/19 (68%) patients. Nineteen patients received I mg atropine intravenously and mean cycle length decreased by 19%, from 891 ± 175.8 msec to 718 ± 182.9 msec. Graded infusion of isoproterenol was employed in 19 patients; four patients required an infusion rate greater than 28.3 ng/kg/min to produce a 20% decrease in spontaneous sinus cycle length. These data would indicate that a variety of interventions are required to characterize the disturbance of sinus node automaticity and sinoatrial conduction in patients with sinus node dysfunction.
tion in order to characterize the nature of the physiologic disturbance in individual patients. Despite the numerous descriptions of patients with sinus node dysfunction, there are no complete detailed electrophysiologic studies of this group of patients available. Such information could be expected to further our understanding of the underlying electrophysiologic mechanisms, and thus provide a more rational basis for pharmacologic therapy in this group of patients.
It was the purpose of this study to evaluate patients with sinus node dysfunction in an attempt to gain insight into the clinical features of these patients and the electrophysiologic mechanisms that underlie disturbances of sinus node function.
Methods
Twenty symptomatic patients with sinus node dysfunction, who were in sinus rhythm at the time of electrophysiologic study, comprise the study group. The patients' ages ranged from 32 to 87 years (mean age 66.2 years). Informed consent was obtained in all patients. History, physical examination, chest X-ray and ECG were performed prior to detailed electrophysiologic study and each patient was classified according to New York Heart Association classification. 54 Sinus bradycardia was evaluated on the basis of its severity and considered to be either persistent or intermittent. Sinus bradycardia was classified as persistent if the range of sinus rhythm recorded at rest during the hospitalization remained below 60 beats/min. It was considered to be minimal if rates ranged between 50 and 59 beats/min; moderate between 40 and 49 beats/min; and severe if the rate fell below 40 beats/min during the period of hospitalization.
At the time of study the patients were in a resting, non Thereafter, in 19/20 patients, programmed premature stimuli were introduced via the stimulating atrial electrode during spontaneous sinus rhythm, as previously described. 42 In this way atrial premature stimuli were introduced after every eighth spontaneous sinus cycle. Stimuli were introduced late in atrial diastole and moved progressively earlier in 5-10 msec decrements, until the entire atrial diastolic period was scanned.42 A two minute stabilization period followed the period of premature atrial stimulation. Twenty consecutive cycles for control pre-pacing cycle length were obtained during the second minute. In 19/20 patients the atria were paced for 60 sec, at constant cycle lengths of 860, 660, 540, 460, 400 and 353 msec. The intervals between pacing were 60-90 sec. During the pacing periods the rhythm was carefully monitored to ensure complete atrial capture.
Five minutes after termination of atrial pacing, an isoproterenol infusion was started. The solution of isoproterenol HCl (2 ,g/ml) and 5% dextrose and water was infused into the dextrose and water infusate at a constant rate. Every five minutes infusion rates were increased by 0.25 ml/min. The rate of infusion was increased until the patient complained of chest pain, developed more than 3-5 ventricular premature depolarizations/min, or until a maximal rate of 120 beats/min was reached. Recordings used in the analysis of cycle length were obtained during the final minute of the infusion period.
Following discontinuation of isoproterenol infusion, the patient's rate was allowed to return to control values over a period of 30-50 minutes, then 1 mg of atropine sulfate was given intravenously. Cycles recorded during the fifth minute following atropine administration were used for analysis of cycle length.
The data were transferred to photographic paper for analysis using an Electronics for Medicine recorder at paper speeds of 100 and 150 mm/sec. Twenty consecutive spontaneous sinus cycles obtained following the initial stabilization period were analyzed for determination of P-P, P-V, A-H, H-V intervals. Atrial activation for the P-V interval was determined from the earliest onset of atrial activity that was detectable in lead II or in the atrial electrogram recording. Atrial (A), His bundle (H) and ventricular (V) activations for A-H, H-V intervals were determined from the onset of the rapid voltage change in the His bundle electrogram recording. P wave and QRS durations were obtained from analysis of ten consecutive lead II cycles. When the spontaneous sinus cycle was interrupted by an atrial premature depolarization (APD), the following four consecutive atrial intervals were measured: 1) spontaneous cycle length (AIAJ), i.e., the interval between the last two spontaneous sinus P waves that preceded the APD; 2) the test cycle (A,A2), i.e., the interval between the last spontaneous sinus P wave and the APD; 3) the return cycle (A2A3), i.e., the interval between the APD and the following P wave; and 4) the spontaneous sinus cycle immediately following the return cycle (A3A4). The atrial intervals used in the analysis of the response to APDs were determined using earliest activation detected. The number of A,A, cycles analyzed corresponded to the number of programmed APDs elicited in any given patient and ranged from 30 to 240 (average 135).
Definitions
The A2A2 interval that followed different A,A2 intervals was not constant but was related to the coupling interval of A2 in a predictable manner which then permitted subdivision of atrial diastole into different zones ( fig. 1) .
The estimated "sinoatrial conduction time" (the sum of retrograde and antegrade sinoatrial conduction time) was considered to be prolonged if it exceeded 215 msec, a value that represented the sum of the mean + I SD (169 + 46 msec) in a series of 20 patients without sinus node dysfunction.56 Unlike our previous study,42 the The functional refractory period of the atrioventricular conduction system (shortest V1-V2 interval) determined during spontaneous sinus rhythm was considered to be prolonged if it exceeded 460 msec, a value that represented the sum of the mean + I SD (419 + 41 msec) in a series of 19 patients with heart disease, but with normal QRS duration and heart rates of 70-100 beats/min. 57 The value of the first escape cycle following termination of pacing was considered to be prolonged if it exceeded a value equal to 1.3 x the mean value of the control spontaneous sinus cycle length + 101 msec, a value that represented the slope of the regression line (1.3 X) + Y intercept (46 msec) +1 SD (estimated to be 55 msec) in a plot of the maximum first escape cycle length against the control spontaneous sinus cycle length. 36 The chronotropic response to atropine was considered to be abnormal if the mean cycle length decreased by less than 17%, a value that represented the mean decrease from control heart rate -I estimated SD (34% -17%) in a series of 39 patients ranging in age from 40 to 79 years without known systemic disease.58
The chronotropic response to isoproterenol was considered to be abnormal if the infusion rate required to produce a 20% decrease in cycle length exceeded 28.3 ng/kg/min, a value that represented the sum of mean + 1 SD (21.0 + 7.3 ng/kg/min) derived from this study group.
Results

Clinical Features
Clinical information on the 20 patients who form the basis of this report is shown in table 1. The patients seen for evaluation had a variety of noncardiac problems. Twelve of the 20 patients were male and 13 were white. Presenting symptoms included dizziness (9/20), syncope (5/20), cerebrovascular accident (2/20), chest pain (7/20) and one patient was asymptomatic. Eleven patients had persistent sinus bradycardia, seven patients had intermittent sinus bradycardia, and two patients did not have sinus bradycardia. Sinus bradycardia was severe in two, moderate in ten, and minimal in six patients. Seven patients had paroxysmal episodes of supraventricular tachyarrhythmias prior to study. Sinus pauses were observed in three patients and sinoatrial block was observed in one patient (No. 16). The etiologies of the heart disease were as listed in table 1. Cardiomegaly was present in 14/20 (70%) patients. Using the New York Heart Association classification,54 four patients were judged as having an uncompromised status (class 1); eight patients had a slightly compromised status (class 2); seven patients had a moderately compromised status (class 3); and one patient had a severely compromised status (class 4).
Eleven patients had some abnormality of atrioventricular nodal and/or intraventricular conduction. Nine of our patients (45%) had first degree atrioventricular block (table  1) . Eight of 20 patients (40%) had an intraventricular conduction disturbance. Seven patients (35%) had QRS complexes that demonstrated marked left axis deviation; in three patients this was the only manifestation of an intraventricular conduction disturbance. Five patients (25%) had prolonged QRS complexes: in two this was due to left bundle branch block, in two to right bundle branch block.
Nine of 20 (45%) patients had artificial pacemaking systems implanted after electrophysiologic study. Six of the nine patients had dizziness, faintness or syncope; three patients had angina and/or congestive heart failure. Symptoms disappeared in five patients and decreased in frequency in three patients. One patient died 24 days postoperatively, six other patients died 5-30 months following pacemaker implantation; thus, 78% of those treated with artificial pacemaker implantation died within 30 months. Pacemaker systems were not implanted in 11 patients. Nine of this latter group of patients are alive 28-47 months following study and one died four months following electrophysiologic study. One patient was lost to follow-up.
Electrophysiological Intervals
Electrophysiological intervals obtained during the control period revealed that 10/20 (50%) patients, at the time of study, had a mean cycle length that was greater than 1000 msec. The P wave duration was greater than 120 msec in 13/20 (65%) of the patients. The P wave was upright in ECG leads I and II in all 20 patients. QRS duration was greater than 120 msec in 4/20 (25%) patients. The mean P-V interval was greater than 210 msec in 7/20 (35%) patients. In this group of seven patients a His bundle electrogram recording was obtained in six and the H-V interval was greater than 55 msec in three patients. Two patients with a prolonged H-V interval had no associated QRS widening. patients the responses to atrial premature depolarizations were so variable as to preclude further analysis. Scatter in the distribution of data points was moderate in five patients ( fig. 2 ) and minimal in the remaining patients ( 1/19) (figs. 3 and 4). Zone I, in which atrial premature depolarizations are usually followed by compensatory return cycles, was identified in all 16 patients who were analyzed. In two patients, atrial premature depolarizations introduced late in atrial diastole were followed by greater than compensatory return cycles as shown in figure 5 . The greater than compensatory A2A3 cycles are described as occurring in Zone I and were associated with a similar prolongation of A3A4 cycles.
The inner limit of Zone I was defined by the transition to Zone II in the graphs (figs. 2-5) and coincided with the appearance of less than compensatory A2A3 cycles as manifested by points falling below the compensatory line. This occurred in 13/16 patients. In the two patients with greater than compensatory A2A3 cycles in Zone I, the transition to a "plateau" response was discrete and at this point the transition between Zone I and II was so identified (fig. 5 ). Thus, the transition from Zone I to II ranged between 66 .6% and 94.7% of the A,A, interval in 15/16 patients Nineteen patients received I mg of atropine intravenously (table 4) ; the mean cycle length for the group decreased by 19%, from 891 ± 175.8 msec to 718 ± 182.9 msec. Eight of 19 patients (42%) showed an abnormal response to atropine, less than 17% decrease; four of these eight patients showed a markedly abnormal response to atropine in that the decrease in mean cycle length was less than 5%.
Graded infusion of isoproterenol was employed in 19 patients (table 4); the target rate was 120 beats/min. The target heart rate was only achieved in one patient; isoproterenol infusion had to be discontinued prematurely in the other 18 patients. The effect on spontaneous cycle length was analyzed by constructing dose response curves as shown in figure 6 . Because isoproterenol infusion rates were not increased to the maximum value necessary to attain a plateau effect in all patients, we selected the rate of isoproterenol infusion (gg/min) which produced a 20% decrease in spontaneous cycle length as a standard value for further comparison. These values were then plotted as a function of the severity of the sinus bradycardia ( fig. 7 ). As can be seen, there is a great variability among patients. In four patients (Nos. 1, 6, 11 and 18) infusion rates >28.3 ng/kg/min, exceeding the mean + 1 SD calculated for our patients, were required to produce a 20% decrease in cycle length. Table 5 summarizes the abnormal responses to each of the test procedures used for each patient.
Discussion
Although the clinical features of the sick sinus syndrome have been reported in detail,"' 3 much remains to be learned about the underlying electrophysiologic mechanisms and pathology. The most important aspect of this study is that it provides clinical and electrophysiological data on 20 IThe escape cycles were expressed as a percentage of the control cycle length. The maximum escape usually coincided with the longest first escape cycle. In some patients the maximum escape cycle appeared in an escape cycle other than the first. The value of the maximum escape cycle, the number of the escape cycle, and the pacing cycle length at whvich the maximum cycle was elicited are noted for each patient.
§The value of the maximum first escape cycle.
patients seen for evaluation of sinus node dysfunction, and a relatively long period of follow-up. One comparison of studies on patients with sick sinus syndrome which can be made at present is the frequency of symptoms. Syncope was present in only 25% (5/20) of our patients, an incidence considerably less than the 45% reduced by pacemaker therapy, the mortality rate seemed to be closely related to the functional status of the patients as 7/9 patients (78%) with pacemakers implanted had functional classification of 3 or 4, whereas only 1/10 patients (10%) who did not receive artificial pacemaker systems had such a functional classification. The response to APDs has been used to evaluate sinoatrial conduction and has been previously reported in detail. 37 42, 44, 59-71 In brief, when APDs are elicited late in atrial diastole, they collide with the emerging sinus node impulse, fail to reset the sinus node and are followed by compensatory return cycles ( fig. 1) . 42, 68 In two patients APDs introduced in Zone I were followed by compensating return cycles that were more than compensatory ( fig. 5) . Such a lengthening of A2A3 cycle could most readily be explained by a lengthening of the sinus node cycle perhaps due to acetylcholine release. Comparable changes in the A3A4 cycle ( fig. 5 ) suggest that the prolongation of the SAN2SAN3 cycle which would artificially prolong the estimated SACT could be compensated for by subtracting A3A4 from A2A3 cycles. As APDs are elicited earlier in diastole the A2A3 cycles become less than compensatory.37 42, 5 Such responses deviate from the compensatory line and go on to form a "plateau" in the graphs as shown in figs. [2] [3] [4] [5] . The A2A3 cycle is determined by the sum of the retrograde and antegrade conduction times between the sinus node and atrium and the sinus node return cycle (SAN2SAN3). In our patients the value of the return cycle as it deviated from the compensatory line (figs. 2 53, No. 5, MAY 1976 the A2A3 cycle can only provide for an approximate estimation of SACT, it remains the only method currently available for probing sinoatrial conduction in vivo. Whether the estimated SACT will prove to be as clinically useful as the P-R interval remains to be determined. A recent study which showed that the estimated SACT was significantly longer in a group of 18 normal subjects72 suggests that determination of the estimated SACT is clinically useful in the evaluation of sinoatrial conduction disturbances in patients with sinus node dysfunction.
The SACT was measured in our 16 patients and found to be prolonged in six (38%). The incidence of prolonged SACT approximated the incidence of first degree A-V block (48%). In fact, five of six patients with a prolonged SACT also had first degree A-V block.
The response to rapid atrial pacing or overdrive suppression has been offered as a technique for evaluating sinus node automaticity.3" " In brief, the degree of prolongation of the escape cycles over the control cycles following termination of pacing is thought to reflect the degree of depression of sinus node automaticity. The success of this technique in the evaluation of sinus node automaticity depends on conduction between the atrium and sinus node being intact during the period of pacing and from the sinus node to the atrium during the post-pacing period, and that alterations of autonomic nervous system tone do not occur during rapid pacing.73 In spite of the lack of specificity for intrinsic sinus node automaticity, sinus node recovery time may be a good test of overall sinus node function. Thirteen of 19 (68%) patients had abnormally prolonged first escape cycles.
In 11 of our patients (58%) the value of the second cycle exceeded that of the first cycle. In these 11 patients the values of the first cycles ranged between 82.2 and 233.7% of the control spontaneous sinus cycle and this range of values would make re-entry seem unlikely as the cause of the short first escape cycles. The more likely explanation, in some instances, is that not all of the atrial impulses are conducting retrograde to capture the sinus node. In five patients the maximal value of the escape cycle occurred in cycles 3 through 10 and exceeded the control cycle length by more than 40%. In only three patients were these secondary sinus pauses of sufficient duration (199.4-1021.7%) to be compatible with sinoatrial block. Although the mathematical relationships of the secondary pauses often are consistent with an exit block mechanism, disturbance of automaticity also has to be considered. Whether these secondary sinus pauses reflect an exaggerated vagal response or a response of a diseased sinus node cannot be determined from these studies. While there were no control studies performed in this study, other studies have reported on the use of this technique in patients without sick sinus syndrome36, 38, 40, 43 and have not described the occurrence of secondary sinus pauses in their control patients. Thus, secondary sinus pauses can be tentatively considered to be an abnormal response to rapid atrial pacing.
Two other techniques available for evaluation of sinus node automaticity are recording the chronotropic response to atropine administration and isoproterenol infusion. 24 41 52,58 The increase in heart rate that follows atropine administration is dependent on the intrinsic cholinergic and adrenergic tone and on the automatic reserve of the sinus node. Although mean changes in cycle length in our patients (20%) are in agreement with those reported by Mandel et al.,41 our patients fell into two groups, those that responded to atropine and those that did not. In the latter group (8 patients) the mean change in cycle length was only -3.9%. The failure of eight patients to show a normal decrease in cycle length in response to atropine could be explained by a defect in parasympathetic, and possibly, in sympathetic regulation of heart rate,74 7 and would be supported by the observation that seven of these eight patients showed a greater than 20% decrease in cycle length during isoproterenol infusion. This observation argues against an intrinsic inability to augment automaticity as being the most important mechanism for the failure of response to atropine.
The positive chronotropic effects of isoproterenol have been studied in man, intact animal hearts and isolated atrial preparations.76"80 We chose the graded infusion method rather than the bolus injection method76 77 (for determination of the dose response relationship) because we thought the latter would be more likely to cause ventricular arrhythmias in patients with heart disease. We compared the infusion rate of isorpoterenol causing a 20% decrease in spontaneous sinus cycle length among our patients ( fig. 6 ). Although tachyphylaxis to infused isoproterenol has been reported,78 evidence of tachyphylaxis was seen in only two of our patients (Nos. 14 and 18). Since we reached the infusion rate of 3.0 ,ug/min at the end of 30 min and used the percent change from control cycle length to calculate the infusion rate causing a 20% decrease in cycle length, we believe that, in this study, the degree of error caused by tachyphylaxis was small.
Graded infusion of isoproterenol produced a 20% or greater decrease in spontaneous cycle length in 17 of 19 patients (89%). The calculated rate of isoproterenol infusion producing a 20% decrease in spontaneous sinus cycle length exceeded 28.3 ng/kg/min in four patients ( fig. 7 ) (Nos. 1, 6, 1 1 and 18). In three of these patients (Nos. 6, 1 1 and 18) abnormal responses to overdrive were also recorded, tending to confirm the presence of a disturbance of automaticity in these patients. On the other hand, these large infusion rates may reflect differences in plasma concentrations of isoproterenol, a disturbance of #3-agonist-receptor interaction, a /-receptor-adenylate cyclase coupling abnormality, as well as a depression of sinus node automaticity. The first possibility can only be ruled out by direct determination of the plasma concentration of isoproterenol and would suggest that such a study in patients with sinus node dysfunction would be of value in interpreting the response to isoproterenol infusion.
In summary, we have shown that a variety of interventions may be necessary to evaluate abnormalities of sinus node automaticity and/or sinoatrial conduction. We selected the mean i1 SD to define a normal range of values for a given intervention. Using such an approach the sensitivity of the functional tests in detecting abnormal responses is rather high, while the specificity is rather low. We used such criteria to minimize the number of false negative tests. In addition, the control values for the different testing procedures, in some instances, were obtained in patients with heart disease, or in the case of the isoproterenol testing, a patient population that had sinus 3) alternate beat Wenckebach phenomenon with two areas of block in the bundle branch system with concealed penetration of the proximal area; 4) concealed re-entry in the right bundle branch system during an H-V Wenckebach cycle with resetting of the sequence of 2:1 H-V block and return of the re-entry wave to the A-V node causing subsequent A-H block; 5) proximal 2:1 block and distal Wenckebach block producing only two consecutively blocked beats; and 6) infrahisian Wenckebach block with changes both in A-V conduction and QRS contour.
Patient I The routine 12-lead ECG taken on a 68-year-old woman with a history of angina pectoris showed an unstable bilateral bundle branch block. When observed by electrophysiological techniques, the variability of the pattern appeared to depend on the rate or intervals at which ventricular depolarization was initiated by sinus or paced impulses. During atrial pacing, standard lead II was recorded simultaneously with an HBE, obtained via a tripolar electrode catheter advanced to the tricuspid valve from the right femoral vein. The standard ECG (0.1-20 Hz) and the HBE (40-500 Hz) were recorded with Electronics for Medicine amplifiers and recorder. Figure 1 shows sinus rhythm at a slightly uneven rate, persistent left bundle branch block (LBBB), and a stable P-R 776
